GBT Guerbet SA

Correction: GUERBET : Financial agenda for 2025

Correction: GUERBET : Financial agenda for 2025

Financial agenda for 2025

Villepinte, 13 janvier 2025: Guerbet (FR0000032526 GBT), a global specialist in contrast agents and solutions for medical imaging, is announcing its financial agenda for 2025.

Publications calendar
  • 2024 ANNUAL REVENUE
February 06, 2025, after trading
  • 2024 ANNUAL RESULTS
March 25, 2025, after trading
  • 2025 1st QUARTER REVENUE
April 24, 2025, after trading
  • ANNUAL SHAREHOLDERS’ MEETING
May 23, 2025
  • 2025 2nd QUARTER REVENUE
July 24, 2025, after trading
  • 2025 FIRST HALF RESULTS
September 22, 2025, after trading
  • 2025 3rd QUARTER REVENUE
October 23, 2025, after trading

About Guerbet

At Guerbet, we build lasting relationships so that we enable people to live better. That is our purpose. We are a leader in medical imaging worldwide, offering a comprehensive range of pharmaceutical products, medical devices, and digital and AI solutions for diagnostic and interventional imaging. A pioneer in contrast media for 95 years, with more than 2,600 employees worldwide, we continuously innovate and devote 10% of our sales to research and development in four centres in France, in United States and Israël. Guerbet (GBT) is listed on Euronext Paris (segment B – mid caps) and generated €786 million in revenue in 2023.

 

 

Contacts:

Guerbet     

Jérôme Estampes, Chief Financial Officer 00 /  

Christine Allard, Head of Public Affairs and Communications: 82 /

Seitosei.Actifin                                                                                       

Marianne Py, Financial Communication 31 /

Jennifer Jullia, Press 19 /

Attachment



EN
13/01/2025

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Guerbet SA

 PRESS RELEASE

GUERBET : Descriptif du programme de rachat d’actions autorisé par l’A...

GUERBET : Descriptif du programme de rachat d’actions autorisé par l’Assemblée Générale Mixte du 23 mai 2025 Descriptif du programme de rachat d’actions autorisé par l’Assemblée Générale Mixte du 23 mai 2025    Villepinte, le 25 juillet 2025 Conformément aux dispositions des articles 241-1 et suivants du Règlement général de l’Autorité des marchés financiers (AMF), Guerbet publie le descriptif de son programme de rachat d’actions, tel qu’autorisé par l’Assemblée Générale Mixte des actionnaires en date du 23 mai 2025. Date de l’Assemblée Générale ayant autorisé le programme de rachat...

Christophe-Raphaël Ganet
  • Christophe-Raphaël Ganet

ResearchPool Subscriptions

Get the most out of your insights

Get in touch